Q1 2023 Holdings
Filed 2023-05-12 | 41 holdings | $210.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $21.7M | 447,092 | 10.3% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $14.5M | 375,500 | 6.9% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $13.6M | 567,826 | 6.5% |
| Humana Inc(HUM) | COM | 444859102 | $11.7M | 24,000 | 5.5% |
| Centene Corp del(CNC) | COM | 15135B101 | $10.2M | 161,404 | 4.8% |
| Kezar Life Sciences Inc | COM | 49372L100 | $10.0M | 3,200,000 | 4.7% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $9.0M | 1,074,593 | 4.2% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $8.9M | 316,165 | 4.2% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $8.8M | 81,035 | 4.2% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $8.8M | 1,545,000 | 4.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $8.1M | 80,000 | 3.8% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $7.7M | 1,488,917 | 3.6% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $6.4M | 3,257,360 | 3.0% |
| Arcturus Therapeutics Hldgs(ARCT) | COM | 03969T109 | $6.1M | 255,000 | 2.9% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $5.9M | 2,021,668 | 2.8% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $5.7M | 753,528 | 2.7% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $5.2M | 10,935 | 2.4% |
| Option Care Health Inc(OPCH) | COM NEW | 68404L201 | $4.9M | 154,900 | 2.3% |
| Quidelortho Corp(QDEL) | COM | 219798105 | $4.3M | 48,355 | 2.0% |
| CUE Biopharma Inc(CUE) | COM | 22978P106 | $4.1M | 1,151,855 | 1.9% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $3.9M | 25,210 | 1.9% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $3.8M | 62,081 | 1.8% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $3.8M | 383,447 | 1.8% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $3.7M | 91,123 | 1.8% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $3.6M | 900,600 | 1.7% |
| Erasca Inc(ERAS) | COM | 29479A108 | $3.5M | 1,179,090 | 1.7% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $2.2M | 678,300 | 1.1% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $2.1M | 876,666 | 1.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.9M | 240,000 | 0.9% |
| Galapagos NVCall | CALL | 36315X901 | $1.5M | 40,000 | 0.7% |
| Modivcare Inc(MODVQ) | COM | 60783X104 | $1.3M | 15,452 | 0.6% |
| Teladoc Health Inc(TDOC) | COM | 87918A105 | $1.2M | 45,900 | 0.6% |
| Kezar Life Sciences IncCall | CALL | 49372L900 | $626.0K | 200,000 | 0.3% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $449.4K | 26,359 | 0.2% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $433.9K | 42,537 | 0.2% |
| Morphic Hldg Inc | COM | 61775R105 | $318.6K | 8,464 | 0.2% |
| Aziyo Biologics Inc(ELUT) | CL A COM | 05479K106 | $296.6K | 196,443 | 0.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $215.5K | 13,000 | 0.1% |
| The Oncology Institute Inc(TOI) | COM | 68236X100 | $191.1K | 281,902 | 0.1% |
| Lifestance Health Group Inc(LFST) | COM | 53228F101 | $66.9K | 9,000 | 0.0% |
| Spdr SER TR(XBI) | S&P BIOTECH | 78464A870 | $20.8K | 273 | 0.0% |